Area:
protein phosphatases
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Andrew M. Slupe is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2011 — 2012 |
Slupe, Andrew |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Regulation of Drp1-Mediated Mitochondrial Fragmentation in Ischemic Brain Injury
Acute injury due to cerebrovascular disease is responsible for significant morbidity and mortality. During ischemic brain injury mitochondria undergo fission resulting in the release of proapoptotic factors which contribute to cell death. The mitochondrial fission machinery, specifically dynamin-related protein 1 (Drp1), has been implicated as a mediator of cell death. Drp1 is regulated by a complex series of posttranslational modifications;however, a full understanding of Drp1 regulation remains to be developed. My long term goal is to characterize the regulatory interaction between the calcium-dependent protein phosphates calcineurin (CaN) and Drp1. It is my hypothesis that calcium influx during ischemia activates CaN to dephosphorylate Drp1, which in turn fragments mitochondria to promote apoptotic and necrotic neuronal death. The specific aims of this proposal are designed to develop a comprehensive model of CaN regulation of Drp1 and investigate the pathophysiological consequences of this regulation in neurons following acute ischemic injury. Aim 1 will identify the molecular determinants for CaN binding to and dephosphorylation of Drp1. Recombinant CaN will be used for phosphates assays and isothermal titration calorimetry to characterize how modification of the Can docking site on Drp1 influences the Can reaction cycle. Further, the molecular determinants of CaN::Drp1 complex formation will be investigated in intact cells by genetic manipulation of a CaN docking site on Drp1 using co-immunoprecipitation studies and western blot analysis with a phospho- state specific Drp1. The objective of these studies will be to first characterize how Can activity is modulated by the Can docking site on target substrates and second to develop a detailed mechanistic understanding of calcium-induced mitochondrial fragmentation in ischemic injury. Aim 2 will characterize the path physiologic impact of Drp1 regulation by CaN in hippocampal neurons. To model the regulation of Drp1 by CaN following stroke, cultured hippocampal neurons will be exposed to toxic levels of glutamate or simulated ischemia in the background of controlled formation and activity of the CaN::Drp1 complex. Following neuronal injury, advanced fluorescence microscopy techniques will be used to probe the role of CaN regulation of Drp1 in dictating mitochondrial morphology, intracellular calcium management and cell survival. The objective of these studies is to assess the potential of the CaN::Drp1 complex as a novel molecular target for therapeutic intervention following neuronal injury.
|
0.915 |